{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:43:41Z","timestamp":1792608221179,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11102-018-0897-z","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T12:25:03Z","timestamp":1527769503000},"page":"631-641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Effectiveness of medical treatment for Cushing\u2019s syndrome: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"21","author":[{"given":"Leonie H. A.","family":"Broersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf M.","family":"Dekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"issue":"5","key":"897_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1210\/edrv.19.5.0346","volume":"19","author":"J Newell-Price","year":"1998","unstructured":"Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing\u2019s syndrome and pseudo-Cushing\u2019s states. Endocr Rev 19(5):647\u2013672. \n                    https:\/\/doi.org\/10.1210\/edrv.19.5.0346","journal-title":"Endocr Rev"},{"issue":"1","key":"897_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1210\/jcem.86.1.7093","volume":"86","author":"J Lindholm","year":"2001","unstructured":"Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of cushing\u2019s syndrome: a population-based study. J Clin Endocrinol Metab 86(1):117\u2013123. \n                    https:\/\/doi.org\/10.1210\/jcem.86.1.7093","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"897_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11102-008-0098-2","volume":"12","author":"E Fernandez-Rodriguez","year":"2009","unstructured":"Fernandez-Rodriguez E, Stewart PM, Cooper MS (2009) The pituitary-adrenal axis and body composition. Pituitary 12(2):105\u2013115. \n                    https:\/\/doi.org\/10.1007\/s11102-008-0098-2","journal-title":"Pituitary"},{"issue":"Suppl1","key":"897_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000314317","volume":"92","author":"AM Pereira","year":"2010","unstructured":"Pereira AM, Tiemensma J, Romijn JA (2010) Neuropsychiatric disorders in Cushing\u2019s syndrome. Neuroendocrinology 92(Suppl1):65\u201370. \n                    https:\/\/doi.org\/10.1159\/000314317","journal-title":"Neuroendocrinology"},{"issue":"1","key":"897_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3171\/jns\/2008\/108\/01\/0009","volume":"108","author":"BM Hofmann","year":"2008","unstructured":"Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Muller OA, Fahlbusch R (2008) Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg 108(1):9\u201318. \n                    https:\/\/doi.org\/10.3171\/jns\/2008\/108\/01\/0009","journal-title":"J Neurosurg"},{"issue":"8","key":"897_CR6","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A (2015) Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807\u20132831. \n                    https:\/\/doi.org\/10.1210\/jc.2015-1818","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"897_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/13543784.2017.1266338","volume":"26","author":"D Ciato","year":"2017","unstructured":"Ciato D, Mumbach AG, Paez-Pereda M, Stalla GK (2017) Currently used and investigational drugs for Cushing s disease. Expert Opin Investig Drugs 26(1):75\u201384. \n                    https:\/\/doi.org\/10.1080\/13543784.2017.1266338","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"897_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5):516\u2013524. \n                    https:\/\/doi.org\/10.1001\/jama.2016.19699","journal-title":"JAMA"},{"issue":"6","key":"897_CR9","doi-asserted-by":"publisher","first-page":"R263-280","DOI":"10.1530\/eje-14-1014","volume":"172","author":"E Daniel","year":"2015","unstructured":"Daniel E, Newell-Price JD (2015) Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing\u2019s syndrome. Eur J Endocrinol 172(6):R263-280. \n                    https:\/\/doi.org\/10.1530\/eje-14-1014","journal-title":"Eur J Endocrinol"},{"issue":"15","key":"897_CR10","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008\u20132012","journal-title":"JAMA"},{"issue":"2","key":"897_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/cen.12286","volume":"80","author":"OF Bosch van den","year":"2014","unstructured":"van den Bosch OF, Stades AM, Zelissen PM (2014) Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing\u2019s disease. Clin Endocrinol 80(2):184\u2013190. \n                    https:\/\/doi.org\/10.1111\/cen.12286","journal-title":"Clin Endocrinol"},{"issue":"4","key":"897_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1530\/EJE-12-0358","volume":"167","author":"C Baudry","year":"2012","unstructured":"Baudry C, Coste J, Bou KR, Silvera S, Guignat L, Guibourdenche J, Abbas H, Legmann P, Bertagna X, Bertherat J (2012) Efficiency and tolerance of mitotane in Cushing\u2019s disease in 76 patients from a single center. Eur J Endocrinol 167(4):473\u2013481. \n                    https:\/\/doi.org\/10.1530\/EJE-12-0358","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"897_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1056\/NEJM197903013000903","volume":"300","author":"JP Luton","year":"1979","unstructured":"Luton JP, Mahoudeau JA, Bouchard P, Thieblot P, Hautecouverture M, Simon D, Laudat MH, Touitou Y, Bricaire H (1979) Treatment of Cushing\u2019s disease by o,p\u2019DDD. Survey of 62 cases. N Engl J Med 300(9):459\u2013464. \n                    https:\/\/doi.org\/10.1056\/NEJM197903013000903","journal-title":"N Engl J Med"},{"issue":"305","key":"897_CR14","first-page":"671","volume":"84","author":"VM Maher","year":"1992","unstructured":"Maher VM, Trainer PJ, Scoppola A, Anderson JV, Thompson GR, Besser GM (1992) Possible mechanism and treatment of o,p\u2019DDD-induced hypercholesterolaemia. QJM 84(305):671\u2013679","journal-title":"QJM"},{"issue":"5","key":"897_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM197107292850501","volume":"285","author":"DN Orth","year":"1971","unstructured":"Orth DN, Liddle GW (1971) Results of treatment in 108 patients with Cushing\u2019s syndrome. N Engl J Med 285(5):243\u2013247. \n                    https:\/\/doi.org\/10.1056\/NEJM197107292850501","journal-title":"N Engl J Med"},{"issue":"4","key":"897_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1210\/jcem-50-4-721","volume":"50","author":"DE Schteingart","year":"1980","unstructured":"Schteingart DE (1980) Suppression of cortisol secretion by human growth hormone. J Clin Endocrinol Metab 50(4):721\u2013725. \n                    https:\/\/doi.org\/10.1210\/jcem-50-4-721","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"897_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1210\/jc.2008-1008","volume":"94","author":"M Boscaro","year":"2009","unstructured":"Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, Reincke M, Snyder P, Tabarin A, Biller BM, Findling J, Melmed S, Darby CH, Hu K, Wang Y, Freda PU, Grossman AB, Frohman LA, Bertherat J (2009) Treatment of pituitary-dependent Cushing\u2019s disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab 94(1):115\u2013122. \n                    https:\/\/doi.org\/10.1210\/jc.2008-1008","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"897_CR18","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1105743","volume":"366","author":"A Colao","year":"2012","unstructured":"Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM (2012) A 12-month phase 3 study of pasireotide in Cushing\u2019s disease. N Engl J Med 366(10):914\u2013924. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1105743","journal-title":"N Engl J Med"},{"issue":"1","key":"897_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/EJE-15-0807","volume":"174","author":"P Burman","year":"2016","unstructured":"Burman P, Eden-Engstrom B, Ekman B, Karlsson FA, Schwarcz E, Wahlberg J (2016) Limited value of cabergoline in Cushing\u2019s disease: a prospective study of a 6-week treatment in 20 patients. Eur J Endocrinol 174(1):17\u201324. \n                    https:\/\/doi.org\/10.1530\/EJE-15-0807","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"897_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1530\/EJE-10-0382","volume":"163","author":"A Godbout","year":"2010","unstructured":"Godbout A, Manavela M, Danilowicz K, Beauregard H, Bruno OD, Lacroix A (2010) Cabergoline monotherapy in the long-term treatment of Cushing\u2019s disease. Eur J Endocrinol 163(5):709\u2013716. \n                    https:\/\/doi.org\/10.1530\/EJE-10-0382","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"897_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1210\/jc.2008-1533","volume":"94","author":"R Pivonello","year":"2009","unstructured":"Pivonello R, De Martino MC, Cappabianca P, De LM, Faggiano A, Lombardi G, Hofland LJ, Lamberts SW, Colao A (2009) The medical treatment of Cushing\u2019s disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. J Clin Endocrinol Metab 94(1):223\u2013230. \n                    https:\/\/doi.org\/10.1210\/jc.2008-1533","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"897_CR22","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2013-3628","volume":"99","author":"F Castinetti","year":"2014","unstructured":"Castinetti F, Guignat L, Giraud P, Muller M, Kamenicky P, Drui D, Caron P, Luca F, Donadille B, Vantyghem MC, Bihan H, Delemer B, Raverot G, Motte E, Philippon M, Morange I, Conte-Devolx B, Quinquis L, Martinie M, Vezzosi D, Le BM, Baudry C, Christin-Maitre S, Goichot B, Chanson P, Young J, Chabre O, Tabarin A, Bertherat J, Brue T (2014) Ketoconazole in Cushing\u2019s disease: is it worth a try? J Clin Endocrinol Metab 99(5):1623\u20131630. \n                    https:\/\/doi.org\/10.1210\/jc.2013-3628","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"897_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2796.1993.tb01018.x","volume":"234","author":"F Fallo","year":"1993","unstructured":"Fallo F, Paoletta A, Tona F, Boscaro M, Sonino N (1993) Response of hypertension to conventional antihypertensive treatment and\/or steroidogenesis inhibitors in Cushing\u2019s syndrome. J Intern Med 234(6):595\u2013598","journal-title":"J Intern Med"},{"issue":"1","key":"897_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4183\/aeb.2015.46","volume":"11","author":"CMV Ghervan","year":"2015","unstructured":"Ghervan CMV, Nemes C, Valea A, Silaghi A, Georgescu CE, Ghervan L (2015) Ketoconazole treatment in Cushing\u2019s syndrome: results of a tertiary referral center in Romania. Acta Endocrinologica-Bucharest 11(1):46\u201354","journal-title":"Acta Endocrinologica-Bucharest"},{"issue":"11","key":"897_CR25","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s001980170025","volume":"12","author":"G Luisetto","year":"2001","unstructured":"Luisetto G, Zangari M, Camozzi V, Boscaro M, Sonino N, Fallo F (2001) Recovery of bone mineral density after surgical cure, but not by ketoconazole treatment, in Cushing\u2019s syndrome. Osteoporos Int 12(11):956\u2013960. \n                    https:\/\/doi.org\/10.1007\/s001980170025","journal-title":"Osteoporos Int"},{"issue":"1","key":"897_CR26","first-page":"26","volume":"67","author":"D Moncet","year":"2007","unstructured":"Moncet D, Morando DJ, Pitoia F, Katz SB, Rossi MA, Bruno OD (2007) Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing\u2019s syndrome. Med-Buenos Aires 67(1):26\u201331","journal-title":"Med-Buenos Aires"},{"issue":"4","key":"897_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1365-2265.1991.tb03547.x","volume":"35","author":"N Sonino","year":"1991","unstructured":"Sonino N, Boscaro M, Paoletta A, Mantero F, Ziliotto D (1991) Ketoconazole treatment in Cushing\u2019s syndrome: experience in 34 patients. Clin Endocrinol 35(4):347\u2013352","journal-title":"Clin Endocrinol"},{"issue":"3","key":"897_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1385\/ENDO:18:3:279","volume":"18","author":"P Stiefel","year":"2002","unstructured":"Stiefel P, Garcia-Morillo JS, Jimenez L, Pamies E, Miranda ML, Carneado J, Villar J, Leal-Cerro A (2002) Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing\u2019s syndrome. Endocrine 18(3):279\u2013284. \n                    https:\/\/doi.org\/10.1385\/ENDO:18:3:279","journal-title":"Endocrine"},{"issue":"1","key":"897_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1200\/JCO.1995.13.1.157","volume":"13","author":"EW Winquist","year":"1995","unstructured":"Winquist EW, Laskey J, Crump M, Khamsi F, Shepherd FA (1995) Ketoconazole in the management of paraneoplastic Cushing\u2019s syndrome secondary to ectopic adrenocorticotropin production. J Clin Oncol 13(1):157\u2013164. \n                    https:\/\/doi.org\/10.1200\/JCO.1995.13.1.157","journal-title":"J Clin Oncol"},{"issue":"2","key":"897_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1530\/acta.0.0820330","volume":"82","author":"DF Child","year":"1976","unstructured":"Child DF, Burke CW, Burley DM, Rees LH, Fraser TR (1976) Drug controlled of Cushing\u2019s syndrome. Combined aminoglutethimide and metyrapone therapy. Acta Endocrinol 82(2):330\u2013341","journal-title":"Acta Endocrinol"},{"issue":"191","key":"897_CR31","first-page":"465","volume":"48","author":"WJ Jeffcoate","year":"1979","unstructured":"Jeffcoate WJ, Silverstone JT, Edwards CR, Besser GM (1979) Psychiatric manifestations of Cushing\u2019s syndrome: response to lowering of plasma cortisol. QJM 48(191):465\u2013472","journal-title":"QJM"},{"issue":"6081","key":"897_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/bmj.2.6081.215","volume":"2","author":"WJ Jeffcoate","year":"1977","unstructured":"Jeffcoate WJ, Rees LH, Tomlin S, Jones AE, Edwards CR, Besser GM (1977) Metyrapone in long-term management of Cushing\u2019s disease. Br Med J 2(6081):215\u2013217","journal-title":"Br Med J"},{"issue":"2","key":"897_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0009-9260(79)80135-X","volume":"30","author":"WM Ross","year":"1979","unstructured":"Ross WM, Evered DC, Hunter P, Benaim M, Cook D, Hall R (1979) Treatment of Cushing\u2019s disease with adrenal blocking drugs and megavoltage therapy to the pituitary. Clin Radiol 30(2):149\u2013153","journal-title":"Clin Radiol"},{"issue":"2","key":"897_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.1991.tb03517.x","volume":"35","author":"JA Verhelst","year":"1991","unstructured":"Verhelst JA, Trainer PJ, Howlett TA, Perry L, Rees LH, Grossman AB, Wass JA, Besser GM (1991) Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing\u2019s syndrome. Clin Endocrinol 35(2):169\u2013178","journal-title":"Clin Endocrinol"},{"issue":"6","key":"897_CR35","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1530\/EJE-09-0098","volume":"160","author":"F Castinetti","year":"2009","unstructured":"Castinetti F, Fassnacht M, Johanssen S, Terzolo M, Bouchard P, Chanson P, Do CC, Morange I, Pico A, Ouzounian S, Young J, Hahner S, Brue T, Allolio B, Conte-Devolx B (2009) Merits and pitfalls of mifepristone in Cushing\u2019s syndrome. Eur J Endocrinol 160(6):1003\u20131010. \n                    https:\/\/doi.org\/10.1530\/EJE-09-0098","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"897_CR36","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1210\/jc.2011-3350","volume":"97","author":"M Fleseriu","year":"2012","unstructured":"Fleseriu M, Biller BM, Findling JW, Molitch ME, Schteingart DE, Gross C (2012) Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 97(6):2039\u20132049. \n                    https:\/\/doi.org\/10.1210\/jc.2011-3350","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"897_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11102-013-0475-3","volume":"17","author":"M Barbot","year":"2014","unstructured":"Barbot M, Albiger N, Ceccato F, Zilio M, Frigo AC, Denaro L, Mantero F, Scaroni C (2014) Combination therapy for Cushing\u2019s disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole? Pituitary 17(2):109\u2013117. \n                    https:\/\/doi.org\/10.1007\/s11102-013-0475-3","journal-title":"Pituitary"},{"issue":"4","key":"897_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1530\/EJE-14-0913","volume":"172","author":"JB Corcuff","year":"2015","unstructured":"Corcuff JB, Young J, Masquefa-Giraud P, Chanson P, Baudin E, Tabarin A (2015) Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole. Eur J Endocrinol 172(4):473\u2013481. \n                    https:\/\/doi.org\/10.1530\/EJE-14-0913","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"897_CR39","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1210\/jc.2015-2616","volume":"100","author":"E Daniel","year":"2015","unstructured":"Daniel E, Aylwin S, Mustafa O, Ball S, Munir A, Boelaert K, Chortis V, Cuthbertson DJ, Daousi C, Rajeev SP, Davis J, Cheer K, Drake W, Gunganah K, Grossman A, Gurnell M, Powlson AS, Karavitaki N, Huguet I, Kearney T, Mohit K, Meeran K, Hill N, Rees A, Lansdown AJ, Trainer PJ, Minder AE, Newell-Price J (2015) Effectiveness of metyrapone in treating Cushing\u2019s syndrome: a retrospective multicenter study in 195 patients. J Clin Endocrinol Metab 100(11):4146\u20134154. \n                    https:\/\/doi.org\/10.1210\/jc.2015-2616","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"897_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/jc.2009-1317","volume":"95","author":"B Donadille","year":"2010","unstructured":"Donadille B, Groussin L, Waintrop C, Abbas H, Tenenbaum F, Dugue MA, Coste J, Bertagna X, Bertherat J (2010) Management of Cushing\u2019s syndrome due to ectopic adrenocorticotropin secretion with 1,ortho-1, para\u2019-dichloro-diphenyl-dichloro-ethane: findings in 23 patients from a single center. J Clin Endocrinol Metab 95(2):537\u2013544. \n                    https:\/\/doi.org\/10.1210\/jc.2009-1317","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"897_CR41","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJMc1000094","volume":"362","author":"RA Feelders","year":"2010","unstructured":"Feelders RA, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, van Heerebeek R, de Jong FH, van der Lely AJ, de Herder WW (2010) Pasireotide alone or with cabergoline and ketoconazole in Cushing\u2019s disease. N Engl J Med 362(19):1846\u20131848. \n                    https:\/\/doi.org\/10.1056\/NEJMc1000094","journal-title":"N Engl J Med"},{"issue":"3","key":"897_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1530\/EJE-16-0662","volume":"176","author":"A Ferriere","year":"2017","unstructured":"Ferriere A, Cortet C, Chanson P, Delemer B, Caron P, Chabre O, Reznik Y, Bertherat J, Rohmer V, Briet C, Raingeard I, Castinetti F, Beckers A, Vroonen L, Maiter D, Cephise-Velayoudom FL, Nunes ML, Haissaguerre M, Tabarin A (2017) Cabergoline for Cushing\u2019s disease: a large retrospective multicenter study. Eur J Endocrinol 176(3):305\u2013314. \n                    https:\/\/doi.org\/10.1530\/EJE-16-0662","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"897_CR43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1365-2265.2012.04424.x","volume":"77","author":"E Valassi","year":"2012","unstructured":"Valassi E, Crespo I, Gich I, Rodriguez J, Webb SM (2012) A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing\u2019s syndrome. Clin Endocrinol 77(5):735\u2013742. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04424.x","journal-title":"Clin Endocrinol"},{"issue":"4","key":"897_CR44","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s11102-012-0452-2","volume":"16","author":"C Bruin de","year":"2013","unstructured":"van der Pas R, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, de Jong FH, van der Lely AJ, de Herder WW, Webb SM (2013) Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing\u2019s disease. Pituitary 16(4):536\u2013544. \n                    https:\/\/doi.org\/10.1007\/s11102-012-0452-2","journal-title":"Pituitary"},{"issue":"2","key":"897_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11102-009-0209-8","volume":"13","author":"L Vilar","year":"2010","unstructured":"Vilar L, Naves LA, Azevedo MF, Arruda MJ, Arahata CM, Silva ME, Agra R, Pontes L, Montenegro L, Albuquerque JL, Canadas V (2010) Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing\u2019s disease. Pituitary 13(2):123\u2013129. \n                    https:\/\/doi.org\/10.1007\/s11102-009-0209-8","journal-title":"Pituitary"},{"issue":"1","key":"897_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s2213-8587(17)30326-1","volume":"6","author":"A Lacroix","year":"2018","unstructured":"Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L, Roughton M, Ravichandran S, Petersenn S, Biller BMK, Newell-Price J (2018) Efficacy and safety of once-monthly pasireotide in Cushing\u2019s disease: a 12 month clinical trial. Lancet Diab Endocrinol 6(1):17\u201326. \n                    https:\/\/doi.org\/10.1016\/s2213-8587(17)30326-1","journal-title":"Lancet Diab Endocrinol"},{"key":"897_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0893-3","author":"LHA Broersen","year":"2018","unstructured":"Broersen LHA, Biermasz NR, van Furth WR, de Vries F, Verstegen MJT, Dekkers OM, Pereira AM (2018) Endoscopic vs. microscopic transsphenoidal surgery for Cushing\u2019s disease: a systematic review and meta-analysis. Pituitary. \n                    https:\/\/doi.org\/10.1007\/s11102-018-0893-3","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-018-0897-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-018-0897-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-018-0897-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:44:39Z","timestamp":1559267079000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-018-0897-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1007\/s11102-018-0897-z","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,31]]},"assertion":[{"value":"31 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}